Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rubicon OrganicsROMJF +4.37%50 Future 3-5Y EPS without NRI Growth Rate is 184.32 as of Sep. 11, 2026. GuruFocus rates ROMJF with a GF Score™ of 50/100 and a GF Value™ of $0.38 (Fairly Valued). The stock has 3 warning signs investors should review. Among 231 Drug Manufacturers companies, Rubicon Organics ranks better than 98.27% on this metric.
Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
As of today, Rubicon Organics's Future 3-5Y EPS without NRI Growth Rate is 184.32.
Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.
Rubicon Organics Future 3-5Y EPS without NRI Growth Rate Related Terms
ROMJF vs ZTS: Future 3-5Y EPS without NRI Growth Rate Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Rubicon Organics's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rubicon Organics Future 3-5Y EPS without NRI Growth Rate vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Rubicon Organics's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Rubicon Organics's Future 3-5Y EPS without NRI Growth Rate falls into.
What does a Future 3-5Y EPS without NRI Growth Rate of 184.32 mean?
Rubicon Organics (ROMJF) has a Future 3-5Y EPS without NRI Growth Rate of 184.32 as of Sep. 11, 2026. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for Rubicon Organics and its competitors. According to the industry distribution chart, Rubicon Organics ranks #4 out of 231 companies in the Drug Manufacturers industry, placing it in the top 1.7%.
Is Rubicon Organics' Future 3-5Y EPS without NRI Growth Rate too high?
Rubicon Organics' current Future 3-5Y EPS without NRI Growth Rate is 184.32. The Drug Manufacturers industry median Future 3-5Y EPS without NRI Growth Rate is 17.15. Rubicon Organics' value of 184.32 is 974.8% above this industry median. Based on the distribution chart, Rubicon Organics ranks #4 out of 231 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Rubicon Organics has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Rubicon Organics' Future 3-5Y EPS without NRI Growth Rate compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Rubicon Organics ranks #4 out of 231 companies for Future 3-5Y EPS without NRI Growth Rate. This places Rubicon Organics in the top 2% of its industry — outperforming the majority of peers. The industry median Future 3-5Y EPS without NRI Growth Rate is 17.15. Rubicon Organics' value of 184.32 is 974.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Future 3-5Y EPS without NRI Growth Rate for a Drug Manufacturers company?
The median Future 3-5Y EPS without NRI Growth Rate among Drug Manufacturers companies is 17.15, based on 231 companies in the industry. Companies in the top quartile (top 25%) have a Future 3-5Y EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, Future 3-5Y EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rubicon Organics's current Future 3-5Y EPS without NRI Growth Rate of 184.32 is 974.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Future 3-5Y EPS without NRI Growth Rate mean?
A high Future 3-5Y EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for Rubicon Organics and its competitors. For the Drug Manufacturers industry, the median Future 3-5Y EPS without NRI Growth Rate is 17.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rubicon Organics's current Future 3-5Y EPS without NRI Growth Rate is 184.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rubicon Organics stock overvalued right now?
Based on GuruFocus' analysis, Rubicon Organics (ROMJF) is currently considered Fairly Valued. The stock's GF Value™ is $0.38, compared to a current price of $0.35 — trading 6.6% below its estimated fair value. The current Future 3-5Y EPS without NRI Growth Rate is 184.32 and 974.8% above the Drug Manufacturers industry median of 17.15. Rubicon Organics' overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Future 3-5Y EPS without NRI Growth Rate calculated?
Future 3-5Y EPS without NRI Growth Rate is calculated from a company's financial statements. For Rubicon Organics (ROMJF), the current Future 3-5Y EPS without NRI Growth Rate is 184.32 as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rubicon Organics (ROMJF) Overvalued in 2026?
Based on GuruFocus' analysis, Rubicon Organics stock appears to be undervalued.
The current stock price of $0.35 is trading 6.6% below its estimated GF Value™ of $0.38.
GuruFocus considers Rubicon Organics to be Fairly Valued.
Key valuation signals for ROMJF:
Future 3-5Y EPS without NRI Growth Rate: 184.32
GF Value™: $0.38 vs. price of $0.35 (6.6% below fair value)
Industry Position: 974.8% above the Drug Manufacturers median (#4 of 231)
No single metric tells the full story. See the ROMJF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rubicon Organics Inc is engaged in the production and sale of cannabis in Canada. The company produces and processes organic cannabis at its wholly owned, federally licensed 125,000 square foot facility in Delta, British Columbia which it sells under its wholly owned brands and certain wholesale channels. Its brands include Simply Bare, 1964 Supply Co, Wildflower, and Homestead Cannabis Supply. It operates in a single reportable segment, being the production and sale of cannabis in Canada.
50GF Score
Get the complete analysis for ROMJF
Future 3-5Y EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROMJF has been successfully added to your 
